- |||||||||| AMP-110 / AstraZeneca, Daiichi Sankyo
Clinical, Journal: Comparison of constant load exercise intensity for verification of maximal oxygen uptake following a graded exercise test in older adults. (Pubmed Central) - Mar 1, 2022
Using the study participant's mean coefficient of variation in peak VO between the two identical ramp tests (2.9%) to compare individual differences between constant load tests and the associated ramp revealed 19/22 (86%) of participants achieved a peak VO during CL85 that was similar or higher versus the ramp, while only 13/20 (65%) of participants achieved a peak VO during CL110 that was similar or higher versus the ramp. These data indicate that if a verification of VO max is warranted when testing older adults, a constant load effort at 85% of ramp peak power may be more likely to verify VO max as compared to an effort at 110% of ramp peak power.
- |||||||||| AMP-110 / AstraZeneca, Daiichi Sankyo
Trial completion, Enrollment change, Trial primary completion date: Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis (clinicaltrials.gov) - Aug 15, 2014
P1, N=26, Completed,
Recruiting --> Completed Active, not recruiting --> Completed | N=21 --> 26 | Trial primary completion date: Dec 2013 --> Jul 2014
- |||||||||| AMP-110 / AstraZeneca, Daiichi Sankyo
Enrollment closed: Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis (clinicaltrials.gov) - Dec 7, 2013
P1, N=21, Active, not recruiting,
Active, not recruiting --> Completed | N=21 --> 26 | Trial primary completion date: Dec 2013 --> Jul 2014 Recruiting --> Active, not recruiting
|
